Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.32 | 10.17 |
| PEG Ratio (TTM) | -1.96 | 0.58 |
| P/S Ratio (TTM) | 1.05 | 1.31 |
| P/B Ratio (TTM) | N/A | 2.41 |
| P/FCF Ratio (TTM) | 9.50 | 22.85 |
| Price to 5YR AVG Earnings Ratio | 11.48 | 13.60 |
| Price to 5YR AVG FCF Ratio | 11.39 | 18.98 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.52% | 12.86% |
| ROE (TTM) | 19.44% | 20.83% |
| Net Profit Margin (TTM) | 11.10% | 12.80% |
| ROIC 5YR AVG | 23.94% | 29.34% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.82% | 42.75% | 24.16% |
| Revenue | -0.05% | 15.26% | 10.20% |
| Net Income | 0.41% | 39.06% | 20.48% |
| Cash Flow | 64.88% | 43.25% | 43.46% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 7.92 |
| Quick Ratio (TTM) | N/A | 2.08 |
| D/E Ratio (TTM) | N/A | 0.29 |
| Interest Coverage (TTM) | 37.23 | 43.29 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | N/A | 6.75 |
| LTL to 5YR AVG FCF | 0.75 | 2.31 |
| Shares Outstanding Growth 5YR AVG | -3.09% | 192.98% |